FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “TRIVERZ”, which is offered here for In the statement, line 14, after medical use, ; except for ophthalmological use should be inserted.;pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use * ; except for ophthalmological use *;color is not claimed as a feature of the mark.;.
Its status is currently believed to be active. Its class is unavailable. “TRIVERZ” is believed to be currently owned by “DAIICHI SANKYO COMPANY, LIMITED”.
| Owner: |
DAIICHI SANKYO COMPANY, LIMITED
Owner Details |
|---|---|
| Description: |
In the Statement, line 14, after MEDICAL USE, ; EXCEPT FOR OPHTHALMOLOGICAL USE should be inserted.;Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use * ; except for ophthalmological use *;Color is not claimed as a feature of the mark.;
|
| Categories: | STATEMENT |